17-44902645-CAGAG-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The ENST00000417826.3(CCDC103):βc.566_569delβ(p.Glu189AlafsTer18) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000229 in 1,613,848 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β ). Synonymous variant affecting the same amino acid position (i.e. A186A) has been classified as Likely benign.
Frequency
Genomes: π 0.000026 ( 0 hom., cov: 32)
Exomes π: 0.000023 ( 0 hom. )
Consequence
CCDC103
ENST00000417826.3 frameshift
ENST00000417826.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.53
Genes affected
CCDC103 (HGNC:32700): (coiled-coil domain containing 103) Enables protein homodimerization activity. Involved in axonemal dynein complex assembly; cilium movement; and determination of left/right symmetry. Predicted to be located in axoneme. Predicted to be part of outer dynein arm. Implicated in primary ciliary dyskinesia 17. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.235 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-44902645-CAGAG-C is Pathogenic according to our data. Variant chr17-44902645-CAGAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 1451307.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC103 | NM_213607.3 | c.566_569del | p.Glu189AlafsTer18 | frameshift_variant | 4/4 | ENST00000417826.3 | NP_998772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC103 | ENST00000417826.3 | c.566_569del | p.Glu189AlafsTer18 | frameshift_variant | 4/4 | 1 | NM_213607.3 | ENSP00000391692 | P1 | |
CCDC103 | ENST00000357776.6 | c.566_569del | p.Glu189AlafsTer18 | frameshift_variant | 4/4 | 2 | ENSP00000350420 | |||
CCDC103 | ENST00000410006.6 | c.566_569del | p.Glu189AlafsTer18 | frameshift_variant | 4/4 | 2 | ENSP00000387252 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152016Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249972Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135204
GnomAD3 exomes
AF:
AC:
4
AN:
249972
Hom.:
AF XY:
AC XY:
4
AN XY:
135204
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461832Hom.: 0 AF XY: 0.0000275 AC XY: 20AN XY: 727224
GnomAD4 exome
AF:
AC:
33
AN:
1461832
Hom.:
AF XY:
AC XY:
20
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74240
GnomAD4 genome
AF:
AC:
4
AN:
152016
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74240
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 06, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CCDC103 protein in which other variant(s) (p.Ser190Argfs*19) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (Invitae). This variant is present in population databases (rs746242380, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Glu189Alafs*18) in the CCDC103 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 54 amino acid(s) of the CCDC103 protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at